Label: KILLA EXTRA STRENGTH 2 PACK- salicylic acid patch

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated May 26, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    ZSK Killa ES 2 pk pouch drug facts

  • ASK DOCTOR

    Ask a doctor if irritation become severe.

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. If swallowed, get medical help or contact a posion Control Center right away.

  • PURPOSE

    Uses:

    • For the management of acne.
    • Penetrates pores to eliminate most blemishes.
  • INACTIVE INGREDIENT

    inactive ingredients

  • DOSAGE & ADMINISTRATION

    directions

  • WARNINGS AND PRECAUTIONS

    For External Use only

  • INDICATIONS & USAGE

    indications

  • WARNINGS

    warnings

  • ZitSticka Killa ES 2 pk pouch pdp

    ZSK Killa ES 2pk pouch

  • INGREDIENTS AND APPEARANCE
    KILLA EXTRA STRENGTH 2 PACK 
    salicylic acid patch
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:81746-526
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID0.0125 mg  in 0.6216 mg
    Inactive Ingredients
    Ingredient NameStrength
    4-BUTYLRESORCINOL (UNII: 2IK4UQ3ZGA)  
    PHYTOSPHINGOSINE HYDROCHLORIDE (UNII: TT871XV7TU)  
    GLYCOLIC ACID (UNII: 0WT12SX38S)  
    OLIGOPEPTIDE-10 (UNII: Q46328TRNK)  
    HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
    MADECASSOSIDE (UNII: CQ2F5O6YIY)  
    NIACINAMIDE (UNII: 25X51I8RD4)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:81746-526-011660 mg in 1 POUCH; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)05/26/2023
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalM00605/26/2023
    Labeler - ZitSticka, Inc. (117778611)
    Establishment
    NameAddressID/FEIBusiness Operations
    Raphas695914964manufacture(81746-526)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!